HMCNX
Price
$14.64
Change
+$0.04 (+0.27%)
Updated
Dec 23 closing price
VIMAX
Price
$330.34
Change
-$1.55 (-0.47%)
Updated
Dec 23 closing price
Ad is loading...

HMCNX vs VIMAX

Header iconHMCNX vs VIMAX Comparison
Open Charts HMCNX vs VIMAXBanner chart's image
Harbor Mid Cap Investor
Price$14.64
Change+$0.04 (+0.27%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Admiral
Price$330.34
Change-$1.55 (-0.47%)
VolumeN/A
CapitalizationN/A
HMCNX vs VIMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HMCNX vs. VIMAX commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HMCNX is a StrongBuy and VIMAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 190B vs. HMCNX (176M). VIMAX pays higher dividends than HMCNX: VIMAX (1.49) vs HMCNX (0.12). HMCNX was incepted earlier than VIMAX: HMCNX (5 years) vs VIMAX (23 years). HMCNX is a more actively managed with annual turnover of: 19.00 vs. VIMAX (13.00). HMCNX has a lower initial minimum investment than VIMAX: HMCNX (2500) vs VIMAX (3000). VIMAX annual gain was more profitable for investors over the last year : 15.92 vs. HMCNX (7.41). VIMAX return over 5 years is better than : 52.16 vs. HMCNX (41.53).
HMCNXVIMAXHMCNX / VIMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years23 years-
Gain YTD7.01815.37946%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets176M190B0%
Annual Yield % from dividends0.121.498%
Returns for 1 year7.4115.9247%
Returns for 3 years-0.326.98-5%
Returns for 5 years41.5352.1680%
Returns for 10 yearsN/A118.50-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AQN4.480.09
+2.05%
Algonquin Power & Utilities Corp
XYL117.510.37
+0.32%
Xylem
DRUG38.690.04
+0.10%
Bright Minds Biosciences
ARDX4.58-0.24
-4.98%
Ardelyx
GDTC2.37-0.19
-7.42%
CytoMed Therapeutics Limited